LJ000328, a novel ALK2/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDA
Date
2020Journal
HaematologicaPublisher
Ferrata Storti FoundationType
Article
Metadata
Show full item recordSponsors
D.M. was supported by the Cooley’s Anemia Foundation, the French Foundation for Rare Diseases, the Région Midi-Pyrénées and ANR (ANR-17-CE14-0036-01 and ANR-17-CE14-0031-01). H.C. and M.-P.R. were supported in part by grants from FRM (DEQ2000326528) and ANR (ANR-13-BSV3-0015-01). This work was also supported by the “Programme des Investissements d’Avenir” ANINFIMIP (ANR-11EQPX-0003).Keyword
iron-refractory iron-deficiency anemiamatriptase-2
kinase inhibitor
LJ000328,
Serine Proteases
Hepcidins
Identifier to cite or link to this item
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081633777&doi=10.3324%2fHAEMATOL.2019.236133&partnerID=40&md5=694f26f2b388f9a983b9b2fdfb7f2cd0; http://hdl.handle.net/10713/12375ae974a485f413a2113503eed53cd6c53
10.3324/HAEMATOL.2019.236133
Scopus Count
Collections
Related articles
- [Iron metabolism and iron-refractory iron deficiency anemia].
- Authors: Suzuki T
- Issue date: 2020
- Hepcidin and the BMP-SMAD pathway: An unexpected liaison.
- Authors: Silvestri L, Nai A, Dulja A, Pagani A
- Issue date: 2019
- ALK3 undergoes ligand-independent homodimerization and BMP-induced heterodimerization with ALK2.
- Authors: Traeger L, Gallitz I, Sekhri R, Bäumer N, Kuhlmann T, Kemming C, Holtkamp M, Müller JC, Karst U, Canonne-Hergaux F, Muckenthaler MU, Bloch DB, Olschewski A, Bartnikas TB, Steinbicker AU
- Issue date: 2018 Dec
- Functional and clinical impact of novel TMPRSS6 variants in iron-refractory iron-deficiency anemia patients and genotype-phenotype studies.
- Authors: De Falco L, Silvestri L, Kannengiesser C, Morán E, Oudin C, Rausa M, Bruno M, Aranda J, Argiles B, Yenicesu I, Falcon-Rodriguez M, Yilmaz-Keskin E, Kocak U, Beaumont C, Camaschella C, Iolascon A, Grandchamp B, Sanchez M
- Issue date: 2014 Nov
- MicroRNA-130a is up-regulated in mouse liver by iron deficiency and targets the bone morphogenetic protein (BMP) receptor ALK2 to attenuate BMP signaling and hepcidin transcription.
- Authors: Zumbrennen-Bullough KB, Wu Q, Core AB, Canali S, Chen W, Theurl I, Meynard D, Babitt JL
- Issue date: 2014 Aug 22